GENPF
Price
$0.01
Change
-$0.03 (-75.00%)
Updated
Jun 6 closing price
Capitalization
1.51M
VPHIF
Price
$0.05
Change
-$0.04 (-44.44%)
Updated
Aug 29 closing price
Capitalization
510.61K
Interact to see
Advertisement

GENPF vs VPHIF

Header iconGENPF vs VPHIF Comparison
Open Charts GENPF vs VPHIFBanner chart's image
GENIX PHARMACEUTICALS
Price$0.01
Change-$0.03 (-75.00%)
Volume$12K
Capitalization1.51M
Valeo Pharma
Price$0.05
Change-$0.04 (-44.44%)
Volume$830
Capitalization510.61K
GENPF vs VPHIF Comparison Chart in %
Loading...
GENPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GENPF vs. VPHIF commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GENPF is a Hold and VPHIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (GENPF: $0.01 vs. VPHIF: $0.05)
Brand notoriety: GENPF and VPHIF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GENPF: 100% vs. VPHIF: 100%
Market capitalization -- GENPF: $1.51M vs. VPHIF: $510.61K
GENPF [@Pharmaceuticals: Generic] is valued at $1.51M. VPHIF’s [@Pharmaceuticals: Generic] market capitalization is $510.61K. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GENPF’s FA Score shows that 0 FA rating(s) are green whileVPHIF’s FA Score has 0 green FA rating(s).

  • GENPF’s FA Score: 0 green, 5 red.
  • VPHIF’s FA Score: 0 green, 5 red.
According to our system of comparison, both GENPF and VPHIF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GENPF’s TA Score shows that 0 TA indicator(s) are bullish.

  • GENPF’s TA Score: 0 bullish, 1 bearish.

Price Growth

GENPF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while VPHIF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GENPF($1.51M) has a higher market cap than VPHIF($511K). VPHIF YTD gains are higher at: 0.000 vs. GENPF (-65.500).
GENPFVPHIFGENPF / VPHIF
Capitalization1.51M511K295%
EBITDA64.1KN/A-
Gain YTD-65.5000.000-
P/E RatioN/AN/A-
Revenue1.07KN/A-
Total Cash4.3KN/A-
Total Debt965KN/A-
TECHNICAL ANALYSIS
Technical Analysis
GENPFVPHIF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
56%
Bullish Trend 4 days ago
43%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
39%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
46%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GENPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIOT4.570.13
+2.93%
PowerFleet Inc.
DUOT6.250.06
+0.97%
Duos Technologies Group
RARE29.01N/A
N/A
Ultragenyx Pharmaceutical
Z85.11-0.16
-0.19%
Zillow Group
SONM0.54-0.05
-8.47%
Sonim Technologies Inc.

GENPF and

Correlation & Price change

A.I.dvisor tells us that GENPF and ARSUF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENPF and ARSUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENPF
1D Price
Change %
GENPF100%
N/A
ARSUF - GENPF
23%
Poorly correlated
N/A
IMCC - GENPF
12%
Poorly correlated
N/A
VPHIF - GENPF
2%
Poorly correlated
N/A
CLCFF - GENPF
2%
Poorly correlated
-2.67%
TRUFF - GENPF
1%
Poorly correlated
-6.81%
More

VPHIF and

Correlation & Price change

A.I.dvisor tells us that VPHIF and VRNOF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VPHIF and VRNOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VPHIF
1D Price
Change %
VPHIF100%
N/A
VRNOF - VPHIF
21%
Poorly correlated
-19.33%
LOVFF - VPHIF
15%
Poorly correlated
-0.25%
TRUFF - VPHIF
8%
Poorly correlated
-6.81%
INNPF - VPHIF
4%
Poorly correlated
-99.14%
GENPF - VPHIF
2%
Poorly correlated
N/A
More